AbbVie

ABBV
Delayed Nyse - 09/21 12:30:00 am
72.39USD
+1%
Prev.71.6700
Open72.0000
High73.0000
Low72.0000
Volume13 097 276
Financials
Sales 2019 33 117 M
EBIT 2019 15 707 M
Net income 2019 9 457 M
Debt 2019 28 994 M
Yield 2019 5,91%
P/E ratio 2019 11,0x
P/E ratio 2020 8,43x
EV / Sales2019 4,11x
EV / Sales2020 3,69x
Capitalization 107 B
Company
AbbVie specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with...
Sector :
Pharmaceuticals - NEC
Calendar :
2019-10-11 ABBVIE : Ex-dividend day for
Trading Rating :
Investor Rating :
Latest news
09/19ABBVIE : Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
PU
09/17ABBVIE : Form 8.3 - Allergan Plc
DJ
09/16ABBVIE : Form 8.3 - AbbVie Inc
AQ
09/16ABBVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/16ABBVIE : Form of prospectus reflecting facts events constituting substantive change from last form
PU
09/16ABBVIE : Report of unscheduled material events or corporate event
PU
09/16ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/16A Plan to Fight Hep C -- WSJ
DJ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance75,384,078,8
Spread/Res.-3,8%-14%-8,1%
Spread/Supp.7,2%15%12%
Support67,563,064,4